Design of Tetrazolium Cations for the Release of Antiproliferative Formazan Chelators in Mammalian Cells.

Abstract

Cancer cells generally present a higher demand for iron, which plays crucial roles in tumor progression and metastasis. This iron addiction provides opportunities to develop broad spectrum anticancer drugs that target iron metabolism. In this context, prochelation approaches are investigated to release metal-binding compounds under specific conditions, thereby limiting off-target toxicity. Here, we demonstrate a prochelation strategy inspired by the bioreduction of tetrazolium cations widely employed to assess the viability of mammalian cells. We designed a series of tetrazolium-based compounds for the intracellular release of metal-binding formazan ligands. The combination of reduction potentials appropriate for intracellular reduction and an N-pyridyl donor on the formazan scaffold led to two effective prochelators. The reduced formazans bind as tridentate ligands and stabilize low-spin Fe(II) centers in complexes of 2:1 ligand-to-metal stoichiometry. The tetrazolium salts are stable in blood serum for over 24 h, and antiproliferative activities at micromolar levels were recorded in a panel of cancer cell lines. Additional assays confirmed the intracellular activation of the prochelators and their ability to affect cell cycle progression, induce apoptotic death, and interfere with iron availability. Demonstrating the role of iron in their intracellular effects, the prochelators impacted the expression levels of key iron regulators (i.e., transferrin receptor 1 and ferritin), and iron supplementation mitigated their cytotoxicity. Overall, this work introduces the tetrazolium core as a platform to build prochelators that can be tuned for activation in the reducing environment of cancer cells and produce antiproliferative formazan chelators that interfere with cellular iron homeostasis.

• Authors: Zoufeng Xu, Yu-Shien Sung, Elisa Tomat
• Journal: Journal of the American Chemical Society (J Am Chem Soc) Vol. 145 Issue 28 Pg. 15197-15206 (07 19 2023) ISSN: 1520-5126 [Electronic] United States
• PMID: 37410992 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural)

Chemical References

• Formazans
• Iron Chelating Agents
• Ligands
• Iron
• Tetrazolium Salts

Topics

• Animals
• Formazans
• Iron Chelating Agents (chemistry, pharmacology)
• Ligands
• Iron (chemistry)
• Tetrazolium Salts
• Mammals (metabolism)